Hematological malignancy Clinical Trials

Delta Trials catalogs 65 clinical trials for Hematological malignancy in its publicly accessible dataset. Within this set, 12 currently recruiting participants and 30 trials have reached completion. This research occurs across 197 participating sites around the world. An additional 23 trials are in other active phases such as not yet recruiting or pending status. Since 2020, 6 trials were withdrawn or terminated prior to completion. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.